O. Amit, R. Heiberger, and P. Lane. Pharmaceutical statistics, 7 (1):
20-35(2008)4522<m:linebreak></m:linebreak>PUBM: Print; CI: (c) 2007; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Presentació de dades.
C. Liu, and L. Blumhardt. Journal of neurology, neurosurgery, and psychiatry, 67 (4):
451-6(October 1999)3144<m:linebreak></m:linebreak>Mesures de contrast.
H. Gardarsdottir, E. Heerdink, and A. Egberts. Pharmacoepidemiology and drug safety, 15 (5):
338-43(May 2006)4368<br/>PUBM: Print; JID: 9208369; 0 (Antidepressive Agents); ppublish;<br/>Mesures de freqüència.
J. Robins, M. Hernán, and A. Rotnitzky. American journal of epidemiology, 166 (9):
994-1002; discussion 1003-4(November 2007)4950<m:linebreak></m:linebreak>GR: R01-HL080644/HL/NHLBI NIH HHS/United States; GR: R37-AI032475/AI/NIAID NIH HHS/United States; JID: 7910653; CON: Am J Epidemiol. 2007 Nov 1;166(9):985-93. PMID: 17875580; 2007/09/17 aheadofprint; ppublish;.
T. Friede, and H. Schmidli. Statistics in medicine, 29 (10):
1145-56(May 2010)5506<m:linebreak></m:linebreak>JID: 8215016; aheadofprint;<m:linebreak></m:linebreak>Sample size; Count data.
T. Lash, and S. Cole. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (23):
e55-6(August 2009)5436<m:linebreak></m:linebreak>JID: 8309333; 2009/07/13 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures d'associació; Immortal time bias.
L. Chen, M. Yen, H. Wu, C. Liao, D. Liou, H. Kuo, and T. Chen. Journal of evaluation in clinical practice, 11 (2):
181-93(April 2005)3816<m:linebreak></m:linebreak>Anàlisi de supervivència; SAS.
C. Howell, T. Dean, L. Lucking, K. Dziedzic, P. Jones, and R. Johanson. BMJ (Clinical research ed.), 325 (7360):
357(August 2002)Exemple d'ITT amb poc sentit. Mirar-se les "rapid responses"<m:linebreak></m:linebreak>
<m:linebreak></m:linebreak>Intention to treat.
J. Cook, P. McCulloch, J. Blazeby, D. Beard, D. Marinac-Dabic, and A. Sedrakyan. BMJ (Clinical research ed.), (January 2013)GR: G1002292/Medical Research Council/United Kingdom; GR: HHSF22321110172C/PHS HHS/United States; JID: 8900488; OID: NLM: PMC3685513; epublish;.
A. Stang, C. Poole, and O. Kuss. European journal of epidemiology, 25 (4):
225-30(April 2010)5552<m:linebreak></m:linebreak>M3: 10.1007/s10654-010-9440-x;<m:linebreak></m:linebreak>Significació estadística.
H. Janes, L. Sheppard, and K. Shepherd. Annals of epidemiology, 18 (10):
792-802(October 2008)4973<m:linebreak></m:linebreak>JID: 9100013; 0 (Air Pollutants); 2008/01/09 received; 2008/05/17 revised; 2008/06/18 accepted; ppublish;.
S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.